Contact
  • Antineo
    • Retour
    • green modern bacteriological laboratory banner 11Antineo
    • Track-Record
    • Mission and Vision
    • Our team
    • Our scientific commitee
    • Animal use at Antineo
  • Preclinical services
    • Retour
    • endpoint assays, drug efficacy studiesPreclinical services
    • In vitro preclinical services
      • Retour
      • In vitro Endpoint studies
      • In vitro continuous-monitoring studies
      • Sample Characterisation
    • Ex vivo preclinical services
    • In vivo preclinical services
    • Preclinical development of immunotherapies
  • Tumour models
    • Retour
    • sans titre 67Tumour models
    • Syngeneic tumour models
      • Retour
      • Liquid tumours in Syngeneic models
      • Solid tumours in Syngeneic models
    • Cell-Derived Xenografts
    • Patient-Derived Xenograft
    • Original preclinical resistant tumour models
  • Our Strengths
    • Retour
    • copie de green modern bacteriological laboratory bannerOur Strengths
    • Facilities & ressources
    • Equipment
    • Networks and Partnerships
  • News & Events
    • Retour
    • News & Events
    • News
    • Press Release
    • Posters
    • Events
    • Upcoming Events
  • Resources
    • Retour
    • Resources
    • Publications
    • Application notes
    • White papers
    • Presentation Corporate 2025

News & Events

Home > News & Events

2026 will be a busy and exciting year for Antineo, as we’ll be attending several key biotech and oncology events across Europe and North America.
Antineo Congress Attendance | 2026
Paris Saclay Cancer Cluster Connect General Assembly 2025
PSCC Connect General Assembly | Paris, France 2025
Antineo at the 14th Tumour Models London Summit
14th Tumour Models London Summit | London, England
Heading to Vienna for BIO-Europe 2025
BIO-EUROPE | Vienna, Austria
We are delighted to announce that we are part of the delegation that will go to Gothenburg and Copenhagen, from October 13 to 16, 2025
Nordic Life Science Days | Gothenburg, Sweden 2025
We are proud to announce the award of EUROSTARS funding for the project SyNaPoC
EUROSTARS funding : Project SyNaPoC
Le Biotuesdays fait sa rentrée ! Vous étiez 165 personnes à vous réunir au Château de Montchat pour cette nouvelle édition.
BioTuesdays | Lyon, France (SEP 2025)
ANTINEO, winner of the France 2030 call for projects !
France 2030 Call for Projects
Hawkcell x Antineo
(WP) MRI monitoring of subcutaneous lymphoma in mice
Antineo au congrès AFSSI à Toulouse !
AFSSI | Toulouse, France 2025
Notre Directrice des études scientifiques Marie Tautou sera au congrès Antibody Industrial Symposium (AIS), les 25 & 26 juin à Tours
13th Antibody Industrial Symposium | Tours, France
Aujourd’hui, Antineo a eu le plaisir de participer à l’OncoSTART-up Summit
OncoSTARTUP Summit | Paris, France
Antineo will be taking part in the Meet2Win conference organized by MATWIN
Meet2Win | Bordeaux, France 2025
Notre Directrice d'études, Marie Tautou et notre CEO, Renaud Marin-Sidgwick, sont ravies de représenter Antineo et de vous présenter nos services lors du BioTuesdays
BioTuesdays | Lyon, France (MAR 2025)
Antineo will be attending the PSCC Innovation Forum 2025 on February 4th in Paris
PSCC Innovation Forum | Paris, France 2025
  • 1
  • 2
  • 3
  • Next page »
Tumour models
  • Cell-Derived Xenografts
  • Syngeneic tumour models
  • Original preclinical resistant tumour models
  • Patient-Derived Xenograft
Preclinical services
  • In vitro preclinical services
  • ex vivo preclinical services
  • in vivo preclinical services
  • Preclinical development of immunotherapies
Our strengths
  • Facilities & Resources
  • Equipment
  • networks and partnerships
Contact & News
  • Contact us
  • News & Events
  • Publication
  • Your career at Antineo !
  • Legals
We use cookies to guarantee you the best experience on our website